ACG Wealth’s Labcorp LH Stock Holding History

ACG Wealth’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-535	Closed	-$108K	–	673
2022 Q2	$108K	Buy	+535	New	+$114K	0.02%	317

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

ACG Wealth's LH Position: Q3 2022 in Review

ACG Wealth sold out of Labcorp (LH) in Q3 2022, closing a stake of 535 shares — an estimated $108K sold.

ACG Wealth first reported a position in LH in Q2 2022 and held it in 1 quarter. The position peaked at $108K in Q2 2022. 936 funds tracked by Wall St. Rank hold LH as of Q3 2022.

ACG Wealth reported no remaining Labcorp position as of Q3 2022 after selling out during the quarter.
ACG Wealth sold 535 Labcorp shares in Q3 2022, an estimated $108K.
ACG Wealth first reported a position in Labcorp in Q2 2022 and held it in 1 quarter.
ACG Wealth's Labcorp position peaked at $108K in Q2 2022.
936 funds tracked by Wall St. Rank held Labcorp as of Q3 2022.

Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.